Option Care Health, Inc. (OPCH)

NasdaqGS · Medical Care Facilities

24.07
+0.70 (+3.00%)
Updated Aug 18, 3:05 PM ET
AI Rating
Buy
Overall Score
72
Trend
75
Momentum
83
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Option Care Health, Inc. is trading at $24.07, up 3.00% on the session. The 50 day average sits at $22.03 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 60, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $21.19 with resistance near $24.70, so that band frames the current range. Average daily movement is roughly $0.75, or about 3.1% of the share price, which is what any stop placement has to allow for. The overall health score of 72 out of 100 combines a trend score of 75, momentum of 83 and a risk score of 52.

Technical indicators

RSI (14)
60.0
strong
MACD
0.624
bullish crossover
SMA 20
23.00
SMA 50
22.03
SMA 200
--
unknown
ATR (14)
0.75
avg daily range
Support
21.19
Resistance
24.70
Volume vs 20d
0.36x
below average
Volatility
41.0%
annualised
1 month
+8.37%
3 months
+20.05%

About Option Care Health, Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.